Grant H. Skrepnek

2.7k total citations
97 papers, 1.9k citations indexed

About

Grant H. Skrepnek is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Grant H. Skrepnek has authored 97 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Economics and Econometrics, 17 papers in Geriatrics and Gerontology and 13 papers in Epidemiology. Recurrent topics in Grant H. Skrepnek's work include Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Medication Adherence and Compliance (8 papers). Grant H. Skrepnek is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (17 papers), Health Systems, Economic Evaluations, Quality of Life (14 papers) and Medication Adherence and Compliance (8 papers). Grant H. Skrepnek collaborates with scholars based in United States, Spain and Trinidad and Tobago. Grant H. Skrepnek's co-authors include Edward P. Armstrong, Joseph L. Mills, David G. Armstrong, Adrienne M. Gilligan, Daniel C. Malone, Duane L. Sherrill, Prasadini Perera, Cecilia M. Plaza, David S. Alberts and Marion Slack and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Grant H. Skrepnek

90 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grant H. Skrepnek United States 24 333 281 271 253 234 97 1.9k
Dong‐Churl Suh United States 26 396 1.2× 289 1.0× 416 1.5× 222 0.9× 174 0.7× 104 2.6k
Charles E. Leonard United States 26 268 0.8× 394 1.4× 191 0.7× 117 0.5× 185 0.8× 127 2.3k
Rebecca S. Boxer United States 26 448 1.3× 129 0.5× 166 0.6× 152 0.6× 237 1.0× 84 2.5k
Fei‐Yuan Hsiao Taiwan 31 773 2.3× 245 0.9× 414 1.5× 130 0.5× 154 0.7× 205 3.0k
Yu Ko Taiwan 27 446 1.3× 352 1.3× 278 1.0× 92 0.4× 97 0.4× 86 1.8k
Daria O’Reilly Canada 31 103 0.3× 389 1.4× 657 2.4× 248 1.0× 246 1.1× 108 3.0k
Alexandra McCarthy Australia 31 196 0.6× 119 0.4× 119 0.4× 330 1.3× 463 2.0× 151 3.0k
Anne Frølich Denmark 26 171 0.5× 257 0.9× 529 2.0× 331 1.3× 251 1.1× 125 2.3k
E Sabaté Switzerland 5 327 1.0× 145 0.5× 226 0.8× 134 0.5× 159 0.7× 11 1.9k
Ataru Igarashi Japan 25 217 0.7× 124 0.4× 669 2.5× 259 1.0× 178 0.8× 197 2.7k

Countries citing papers authored by Grant H. Skrepnek

Since Specialization
Citations

This map shows the geographic impact of Grant H. Skrepnek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant H. Skrepnek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant H. Skrepnek more than expected).

Fields of papers citing papers by Grant H. Skrepnek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grant H. Skrepnek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant H. Skrepnek. The network helps show where Grant H. Skrepnek may publish in the future.

Co-authorship network of co-authors of Grant H. Skrepnek

This figure shows the co-authorship network connecting the top 25 collaborators of Grant H. Skrepnek. A scholar is included among the top collaborators of Grant H. Skrepnek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grant H. Skrepnek. Grant H. Skrepnek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Gentry, Chris A., et al.. (2018). Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study. Clinical Microbiology and Infection. 25(8). 987–993. 24 indexed citations
3.
4.
Skrepnek, Grant H., et al.. (2018). Overview of Prescription Opioid Deaths in the Oklahoma State Medicaid Population, 2012–2016. Medical Care. 56(8). 727–735. 5 indexed citations
5.
Altyar, Ahmed E., et al.. (2015). Clinical and economic characteristics of emergency department visits due to acetaminophen toxicity in the USA. BMJ Open. 5(9). e007368–e007368. 28 indexed citations
6.
Skrepnek, Grant H. & Ankit Sahai. (2014). Improved bootstrap point and confidence interval estimation of the incremental cost-effectiveness ratio (ICER). Value in Health. 17(3). A201–A201. 1 indexed citations
7.
Skrepnek, Grant H. & Ashok Sahai. (2013). Efficient Point Estimation of the Sharpe Ratio. RePEc: Research Papers in Economics. 2(4). 1–9. 1 indexed citations
8.
Armstrong, Edward P., et al.. (2013). Is scorpion antivenom cost-effective as marketed in the United States?. Toxicon. 76. 394–398. 16 indexed citations
9.
Perera, Prasadini, Edward P. Armstrong, Duane L. Sherrill, & Grant H. Skrepnek. (2012). Acute Exacerbations of COPD in the United States: Inpatient Burden and Predictors of Costs and Mortality. COPD Journal of Chronic Obstructive Pulmonary Disease. 9(2). 131–141. 166 indexed citations
10.
Armstrong, Edward P., Grant H. Skrepnek, Medha Sasané, Susan Snodgrass, & Samir K. Ballas. (2012). Long-term persistency and costs associated with the use of iron chelation therapies in the treatment of Sickle cell disease within Medicaid programs. Journal of Medical Economics. 16(1). 10–18. 9 indexed citations
11.
Amini, Albert, Asad E. Patanwala, Felipe B. Maegawa, et al.. (2012). Effect of epidural analgesia on postoperative complications following pancreaticoduodenectomy. The American Journal of Surgery. 204(6). 1000–1006. 34 indexed citations
12.
Skrepnek, Grant H. & Ashok Sahai. (2011). An Estimation Error Corrected Sharpe Ratio Using Bootstrap Resampling. Journal of Applied Finance and Banking. 1(2). 1–10. 2 indexed citations
13.
Skrepnek, Grant H., et al.. (2011). Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.. PubMed. 58(6). 484–92; quiz 493. 6 indexed citations
14.
Skrepnek, Grant H., et al.. (2008). The cost-effectiveness of sertraline in the treatment of depression. Expert Opinion on Pharmacotherapy. 9(14). 2497–2508. 6 indexed citations
15.
Ko, Yu, Daniel C. Malone, Jerome V. D’Agostino, et al.. (2008). Potential Determinants of Prescribers' Drug-Drug Interaction Knowledge. Research in Social and Administrative Pharmacy. 4(4). 355–366. 26 indexed citations
16.
Skrepnek, Grant H., et al.. (2008). Cost-effectiveness of urokinase and alteplase for treatment of acute peripheral artery disease: Comparison in a decision analysis model. American Journal of Health-System Pharmacy. 65(15). 1435–1442. 2 indexed citations
17.
Plaza, Cecilia M., et al.. (2007). Curriculum Mapping in Program Assessment and Evaluation. American Journal of Pharmaceutical Education. 71(2). 20–20. 77 indexed citations
18.
Grizzle, Amy J., Yu Ko, John E. Murphy, et al.. (2007). Reasons provided by prescribers when overriding drug-drug interaction alerts.. PubMed. 13(10). 573–8. 70 indexed citations
19.
Skrepnek, Grant H.. (2007). The Contrast and Convergence of Bayesian and Frequentist Statistical Approaches in Pharmacoeconomic Analysis. PharmacoEconomics. 25(8). 649–664. 10 indexed citations
20.
Abarca, Jacob, Daniel C. Malone, Grant H. Skrepnek, et al.. (2006). Community Pharmacy Managers' Perception of Computerized Drug—Drug Interaction Alerts. Journal of the American Pharmacists Association. 46(2). 148–153. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dong‐Churl Suh Breakdown of academic impact, for papers by Charles E. Leonard Breakdown of academic impact, for papers by Rebecca S. Boxer Breakdown of academic impact, for papers by Fei‐Yuan Hsiao Breakdown of academic impact, for papers by Yu Ko Breakdown of academic impact, for papers by Daria O’Reilly Breakdown of academic impact, for papers by Alexandra McCarthy Breakdown of academic impact, for papers by Anne Frølich Breakdown of academic impact, for papers by E Sabaté Breakdown of academic impact, for papers by Ataru Igarashi
Rankless by CCL
2026